Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation

NCT07418138 is registered in ClinicalTrials.gov with Hu Liangshuo as lead sponsor.

NCT NCT07418138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07418138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation
Lead sponsor
Hu Liangshuo
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
December 31, 2024
Enrollment
484 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma (hcc), liver transplantation, survival rate, tyrosine kinase inhibitor